| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | ZnF_C2HC | 1.13e-06 | 55 | 63 | 5 | SM00343 | |
| Domain | Znf_CCHC | 1.13e-06 | 55 | 63 | 5 | IPR001878 | |
| Domain | SPRY | 2.12e-04 | 87 | 63 | 4 | SM00449 | |
| Domain | SPRY | 2.86e-04 | 94 | 63 | 4 | PF00622 | |
| Domain | SPRY_dom | 2.86e-04 | 94 | 63 | 4 | IPR003877 | |
| Domain | B30.2/SPRY | 2.97e-04 | 95 | 63 | 4 | IPR001870 | |
| Domain | B302_SPRY | 2.97e-04 | 95 | 63 | 4 | PS50188 | |
| Domain | IGc2 | 1.17e-03 | 235 | 63 | 5 | SM00408 | |
| Domain | Ig_sub2 | 1.17e-03 | 235 | 63 | 5 | IPR003598 | |
| Domain | Znf_FYVE_PHD | 1.53e-03 | 147 | 63 | 4 | IPR011011 | |
| Domain | PHD | 2.08e-03 | 75 | 63 | 3 | PF00628 | |
| Domain | WD40_repeat_CS | 2.28e-03 | 164 | 63 | 4 | IPR019775 | |
| Domain | Znf_PHD-finger | 2.41e-03 | 79 | 63 | 3 | IPR019787 | |
| Domain | PHD | 3.38e-03 | 89 | 63 | 3 | SM00249 | |
| Domain | Znf_PHD | 3.60e-03 | 91 | 63 | 3 | IPR001965 | |
| Domain | Ig_I-set | 3.87e-03 | 190 | 63 | 4 | IPR013098 | |
| Domain | I-set | 3.87e-03 | 190 | 63 | 4 | PF07679 | |
| Domain | - | 3.99e-03 | 449 | 63 | 6 | 3.30.40.10 | |
| Domain | ZF_PHD_2 | 4.06e-03 | 95 | 63 | 3 | PS50016 | |
| Domain | ZF_PHD_1 | 4.18e-03 | 96 | 63 | 3 | PS01359 | |
| Domain | Znf_RING/FYVE/PHD | 4.44e-03 | 459 | 63 | 6 | IPR013083 | |
| Domain | - | 5.28e-03 | 333 | 63 | 5 | 2.130.10.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 5.41e-03 | 335 | 63 | 5 | IPR015943 | |
| Domain | IG_LIKE | 6.14e-03 | 491 | 63 | 6 | PS50835 | |
| Domain | ConA-like_dom | 6.38e-03 | 219 | 63 | 4 | IPR013320 | |
| Domain | Ig-like_dom | 6.88e-03 | 503 | 63 | 6 | IPR007110 | |
| Domain | SET | 8.44e-03 | 41 | 63 | 2 | PF00856 | |
| Domain | Ig-like_fold | 9.45e-03 | 706 | 63 | 7 | IPR013783 | |
| Pubmed | FAM90A14 FAM90A17 FAM90A19 FAM90A22 FAM90A23 FAM90A1 FAM90A18 FAM90A9 FAM90A8 FAM90A16 | 3.21e-21 | 25 | 74 | 10 | 17684299 | |
| Pubmed | FAM90A14 FAM90A17 FAM90A19 FAM90A22 FAM90A23 FAM90A9 FAM90A8 FAM90A16 | 1.36e-16 | 23 | 74 | 8 | 18602769 | |
| Pubmed | Placental PPARγ regulates spatiotemporally diverse genes and a unique metabolic network. | FAM90A14 FAM90A17 FAM90A19 FAM90A22 FAM90A26 FAM90A23 TMEM125 FAM90A1 FAM90A9 FAM90A8 | 2.28e-12 | 164 | 74 | 10 | 22967998 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | HIVEP3 RANBP10 CELSR1 ATG10 NSD1 GRID1 WDR90 ZFPM1 BCAM HERC1 ZZEF1 PRAG1 ULK2 ZNF503 | 7.60e-08 | 1105 | 74 | 14 | 35748872 |
| Pubmed | NYAP: a phosphoprotein family that links PI3K to WAVE1 signalling in neurons. | 1.38e-05 | 22 | 74 | 3 | 21946561 | |
| Pubmed | 2.67e-05 | 4 | 74 | 2 | 29143738 | ||
| Pubmed | 4.45e-05 | 5 | 74 | 2 | 9628876 | ||
| Pubmed | Rectification of muscle and nerve deficits in paralyzed ryanodine receptor type 1 mutant embryos. | 6.66e-05 | 6 | 74 | 2 | 26025922 | |
| Pubmed | 1.24e-04 | 8 | 74 | 2 | 21441923 | ||
| Pubmed | 1.24e-04 | 8 | 74 | 2 | 19776380 | ||
| Pubmed | 1.99e-04 | 10 | 74 | 2 | 15601870 | ||
| Pubmed | 2.49e-04 | 57 | 74 | 3 | 18022353 | ||
| Pubmed | De novo genic mutations among a Chinese autism spectrum disorder cohort. | 2.91e-04 | 12 | 74 | 2 | 27824329 | |
| Pubmed | Sexual differentiation in the developing mouse brain: contributions of sex chromosome genes. | 2.91e-04 | 12 | 74 | 2 | 23210685 | |
| Pubmed | 2.91e-04 | 12 | 74 | 2 | 20018852 | ||
| Pubmed | MOF-associated complexes ensure stem cell identity and Xist repression. | 3.43e-04 | 13 | 74 | 2 | 24842875 | |
| Pubmed | 5.26e-04 | 16 | 74 | 2 | 19948886 | ||
| Pubmed | 5.95e-04 | 17 | 74 | 2 | 20479123 | ||
| Pubmed | 6.46e-04 | 493 | 74 | 6 | 15368895 | ||
| Pubmed | 7.46e-04 | 19 | 74 | 2 | 17554007 | ||
| Pubmed | 8.28e-04 | 20 | 74 | 2 | 19047629 | ||
| Pubmed | PRDM16 determines specification of ventricular cardiomyocytes by suppressing alternative cell fates. | 9.14e-04 | 21 | 74 | 2 | 39304345 | |
| Pubmed | 1.00e-03 | 22 | 74 | 2 | 23975195 | ||
| Pubmed | Cbln1 regulates axon growth and guidance in multiple neural regions. | 1.00e-03 | 22 | 74 | 2 | 36395107 | |
| Pubmed | 1.29e-03 | 100 | 74 | 3 | 10048485 | ||
| Pubmed | 1.40e-03 | 103 | 74 | 3 | 10819331 | ||
| Pubmed | 1.40e-03 | 26 | 74 | 2 | 10920247 | ||
| Pubmed | 1.63e-03 | 28 | 74 | 2 | 12471243 | ||
| Pubmed | Identification and characterization of a novel human PP1 phosphatase complex. | 2.00e-03 | 31 | 74 | 2 | 20516061 | |
| Pubmed | The cooperative action of CSB, CSA, and UVSSA target TFIIH to DNA damage-stalled RNA polymerase II. | 2.00e-03 | 31 | 74 | 2 | 32355176 | |
| Pubmed | 2.00e-03 | 31 | 74 | 2 | 29099309 | ||
| Interaction | FAM90A26 interactions | 9.01e-06 | 2 | 61 | 2 | int:FAM90A26 | |
| Interaction | KAT8 interactions | 1.01e-05 | 95 | 61 | 5 | int:KAT8 | |
| Cytoband | 8p23.1 | FAM90A14 FAM90A17 FAM90A19 FAM90A22 LINC00208 FAM90A23 PRAG1 FAM90A18 FAM90A9 FAM90A8 FAM90A16 | 1.47e-15 | 154 | 74 | 11 | 8p23.1 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8p23 | FAM90A14 FAM90A17 FAM90A19 FAM90A22 LINC00208 FAM90A23 PRAG1 FAM90A18 FAM90A9 FAM90A8 FAM90A16 | 1.50e-13 | 234 | 74 | 11 | chr8p23 |
| Cytoband | 10q22.2 | 4.10e-05 | 41 | 74 | 3 | 10q22.2 | |
| GeneFamily | Zinc fingers C2HC-type|PHD finger proteins|Lysine acetyltransferases | 9.13e-04 | 16 | 51 | 2 | 66 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.09e-03 | 161 | 51 | 4 | 593 | |
| GeneFamily | Beta 3-glycosyltransferases | 2.07e-03 | 24 | 51 | 2 | 426 | |
| GeneFamily | PHD finger proteins | 2.09e-03 | 90 | 51 | 3 | 88 | |
| GeneFamily | Immunoglobulin like domain containing | 2.13e-03 | 193 | 51 | 4 | 594 | |
| GeneFamily | Autophagy related | 3.90e-03 | 33 | 51 | 2 | 1022 | |
| GeneFamily | WD repeat domain containing | 6.32e-03 | 262 | 51 | 4 | 362 | |
| GeneFamily | Ubiquitin specific peptidases | 1.09e-02 | 56 | 51 | 2 | 366 | |
| Coexpression | GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH2_UP | 8.97e-06 | 198 | 64 | 6 | M5591 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.77e-07 | 197 | 66 | 6 | b94645d57efe8d9e032bffb8c89af1f425c6421e | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.77e-07 | 197 | 66 | 6 | 1485933986921ff45669d9b7501c8d17050b3e97 | |
| ToppCell | LPS_only-Epithelial_alveolar|LPS_only / Treatment groups by lineage, cell group, cell type | 4.91e-07 | 198 | 66 | 6 | 655df75b9692d815c7f6910275e1f684ac63bf62 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.91e-07 | 198 | 66 | 6 | 285f729140b1df029c24f6ca1d2438470ac51794 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.06e-07 | 199 | 66 | 6 | a270630626df614f8605abddb7dee7c4d74f6149 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.06e-07 | 199 | 66 | 6 | 1c70e7d6bd25980e1b92aa1cac3f3c95d9651b4b | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.91e-06 | 184 | 66 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.91e-06 | 184 | 66 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.91e-06 | 184 | 66 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.91e-06 | 184 | 66 | 5 | 7cc5796557379c3d1db078c1aeda40659c6e401c | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.12e-06 | 185 | 66 | 5 | c82eab551f65ecebe6db908eda9f9eb3414693c7 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.55e-06 | 187 | 66 | 5 | 4ae7465174e0295d2c3b614b321a3b2f514dd22a | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.78e-06 | 188 | 66 | 5 | eea652bab161f19148a883e7e3fe2523b36b3cea | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.01e-06 | 189 | 66 | 5 | b60c8a29d3169c4830fe63b01db90c57660fc239 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 1.10e-05 | 197 | 66 | 5 | 1a1bee8da6e04b65935c40373eaee4d6c046d9a1 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2|Control_saline / Treatment groups by lineage, cell group, cell type | 1.10e-05 | 197 | 66 | 5 | b8f62fcd6eb8f47b3cc41f616126f82c68a36e87 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.13e-05 | 198 | 66 | 5 | aa80315395cb5dffc25927c8a77cd2037aea8772 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.18e-05 | 200 | 66 | 5 | e8db082aa4d0597500e4f16a5c0ea3e62c6c59ae | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.18e-05 | 200 | 66 | 5 | ddfb1f006365bf16203ee49f20200f68220cc288 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1|LPS_only / Treatment groups by lineage, cell group, cell type | 1.18e-05 | 200 | 66 | 5 | 9a6ae40f3e17cd44ee5fd73260713b920aa2ea15 | |
| ToppCell | Healthy_donor-B_cell|World / disease group, cell group and cell class (v2) | 7.28e-05 | 150 | 66 | 4 | a2dfed562de7f58f902b547acec5a13853c80c4c | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Myeloid-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.35e-05 | 160 | 66 | 4 | 984990be02642a562f0c60ea99c01f005e7c02c2 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.81e-05 | 162 | 66 | 4 | 373513f9d0e5007b2e10a8b78d4909dcce9e3b62 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.08e-04 | 166 | 66 | 4 | 4d63c758d46e73311b864148c646bf081498dee7 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-J_(Lipofibroblast)|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.08e-04 | 166 | 66 | 4 | 4160ccf9291072a6e2782f9ad141bc9a9747f3ad | |
| ToppCell | Control-Epithelial_cells-Airway_basal|Control / group, cell type (main and fine annotations) | 1.21e-04 | 171 | 66 | 4 | 3965ced4be6db14265a90673502fceee425837ca | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-04 | 173 | 66 | 4 | f612d4ea9ab8dcde475f4118bca3e49be786e7fa | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-04 | 173 | 66 | 4 | c62e3ffed55bbb00dcaef6da0aab8446f3f55085 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Basal/Suprabasal-Basal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.38e-04 | 177 | 66 | 4 | ce86dfaeb74d995a19aea62f0fb15c4c0bb854b0 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Basal/Suprabasal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.38e-04 | 177 | 66 | 4 | cbad1a23851151dbef01ea2af960e6f0944f838b | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.38e-04 | 177 | 66 | 4 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.47e-04 | 180 | 66 | 4 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | Control-Epithelial-Basal|World / Disease state, Lineage and Cell class | 1.54e-04 | 182 | 66 | 4 | 759390dde9b18757f7675d13d44c89d0e32f8d93 | |
| ToppCell | Control-Epithelial-Basal|Control / Disease state, Lineage and Cell class | 1.54e-04 | 182 | 66 | 4 | caddd0a52f0234ea6a916186ffaf2454cdcd80ee | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-04 | 182 | 66 | 4 | a8cc56f32efe180e8fb5d69dbe606a794b3db700 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.54e-04 | 182 | 66 | 4 | 17ed11a7ea366dd3106400511d5e628d3f1a9c3e | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.57e-04 | 183 | 66 | 4 | 5f2db95d44b7de68779de098892892af540fd431 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.57e-04 | 183 | 66 | 4 | 5472cdce6d99314d229418412acf1fff6340db7d | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.57e-04 | 183 | 66 | 4 | ff6dde877659cde9daa3263db0932c9c9ef1adac | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.57e-04 | 183 | 66 | 4 | e972432dd4d1bd31bb0982f4df3061e5e152658f | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.60e-04 | 184 | 66 | 4 | cdf6f1c6cce97a7effa0c55959652e2c0b6992b3 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.60e-04 | 184 | 66 | 4 | 42ce855b4f8475a8298192feec785bdc69bc5bb0 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.60e-04 | 184 | 66 | 4 | 5939527d24d299e562e707469c9123890edd76be | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.63e-04 | 185 | 66 | 4 | fefaf227d89f680d6f3e91c4a94e26ab4d0dc6c3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.63e-04 | 185 | 66 | 4 | b848b63aff4d9dbb9e66a85876d4c7c6dacd0579 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 1.63e-04 | 185 | 66 | 4 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.63e-04 | 185 | 66 | 4 | b8d02c9426740ffcb69d2e6f95473b388149d297 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.67e-04 | 186 | 66 | 4 | 3aebe163799109ffc67e4e10ee47c2dd0886a92c | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.70e-04 | 187 | 66 | 4 | b71d0cd91bc98e020757c1d071a13ad48d718bcf | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.70e-04 | 187 | 66 | 4 | f0de86ef25e344d9b1860ee26308877d6c25ed31 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.70e-04 | 187 | 66 | 4 | ff26a533d310126521efe1d05cf8b9d32e524550 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.70e-04 | 187 | 66 | 4 | 201ff693e4756ee3e44762885b3a303a77eb535b | |
| ToppCell | COVID-19-Epithelial_cells-Airway_basal|COVID-19 / group, cell type (main and fine annotations) | 1.70e-04 | 187 | 66 | 4 | 8407a82e98f56a94ea26562bcb6bbe00a8f41661 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.74e-04 | 188 | 66 | 4 | b04fd6a724c117eb9a979c29b91f90113feb7a5c | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.74e-04 | 188 | 66 | 4 | 14072d0b82df55711d5356b2209f4f0bdd90dc27 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.74e-04 | 188 | 66 | 4 | 60242c29c7f16c94a84685d3bc4ed93a66e70152 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.74e-04 | 188 | 66 | 4 | 43a0508d2524a5b310e89e9422843dcaab999bc3 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.77e-04 | 189 | 66 | 4 | 70eea8c94fa56bb15bee8065de47acea156794e9 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.77e-04 | 189 | 66 | 4 | 5f883ef4cc0383142d538ae61f4fb40dfdb8ef18 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.85e-04 | 191 | 66 | 4 | 2110a1dd10730ad7ee7a265fb1716ab3ddafcf4a | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-04 | 191 | 66 | 4 | 5c1f5b6c115b1b27b4a7467a6550ce43c01cf6d0 | |
| ToppCell | IPF-Epithelial-Club|World / Disease state, Lineage and Cell class | 1.85e-04 | 191 | 66 | 4 | 3c88a6f1d74bb3b9173cd0ea3a63c6d9570e3954 | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-04 | 192 | 66 | 4 | eb9a0b3d32f90f8b95905c740aab21639dae5cbd | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.92e-04 | 193 | 66 | 4 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | ASK440-Epithelial-Secretory|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.92e-04 | 193 | 66 | 4 | 50e98d91697c7af6a3de39e52edde6dd2b67b512 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-Secretory/RAS-RAS|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.96e-04 | 194 | 66 | 4 | a58841b34efe673671a9a059238e044a7254b279 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-Secretory/RAS|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.96e-04 | 194 | 66 | 4 | 0cd4363627acd419e00d6d32f6dce10430aa6487 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Club|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.04e-04 | 196 | 66 | 4 | 057d150bdf0cad959fd03ec2d1560a96ba03fae9 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 2.08e-04 | 197 | 66 | 4 | 44a59dfb889577b3160a5b13ada1276771a00241 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Club|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.08e-04 | 197 | 66 | 4 | 3f5dfa892a1f631b96eeb6f4cfc284aee51d1ce6 | |
| ToppCell | (08)_Brush+PNEC-(0)_Reference|(08)_Brush+PNEC / shred by cell type by condition | 2.08e-04 | 197 | 66 | 4 | d500bfed2a76f7300f2f17b60962c18a40efd084 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.08e-04 | 197 | 66 | 4 | 1638959d7aecb9fc5285eb7e4a3103ca437989e2 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.08e-04 | 197 | 66 | 4 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.12e-04 | 198 | 66 | 4 | b598ab958e31f1e98bd06dc0097b58ac3a3f90a3 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2|LPS_only / Treatment groups by lineage, cell group, cell type | 2.12e-04 | 198 | 66 | 4 | d087e738d69ca9853553fde46d4e7a8906439d32 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-2_Progenitor-AT2_Progenitor|Control_saline / Treatment groups by lineage, cell group, cell type | 2.12e-04 | 198 | 66 | 4 | 030ef63e2fc5b3d601c1a48462d797aa19ee7ff5 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1|Control_saline / Treatment groups by lineage, cell group, cell type | 2.12e-04 | 198 | 66 | 4 | 85f424cd9bb3117c9e322031024aabb87696ce47 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-2_Progenitor-AT2_Progenitor|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.12e-04 | 198 | 66 | 4 | 82bcd44f8744e7e8477fbfd871a52f3d1a8b3adc | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_secretory|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.16e-04 | 199 | 66 | 4 | 7223f853335492ca617dbec3e4b6872a8a463a45 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Goblet|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.16e-04 | 199 | 66 | 4 | e03bdc7cb825e287f41b834ec6061d23c1c03b04 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.16e-04 | 199 | 66 | 4 | 6fb5f931e6217142de38c1fffc011e63bda4772b | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.16e-04 | 199 | 66 | 4 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.16e-04 | 199 | 66 | 4 | 5d2e85e40b6b52b1809e680b952913d77215b3d0 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.16e-04 | 199 | 66 | 4 | 121de4e02585de3a3010398387c523bacf8ce546 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.16e-04 | 199 | 66 | 4 | 1bb5797e8e0552bf9b44bf4c958d1aa6dbe6c756 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.16e-04 | 199 | 66 | 4 | 9dd4b17fb8c70ab9e126b23b72600463f3db832d | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.20e-04 | 200 | 66 | 4 | c89f3cb36bb14c476d6a392bfd3ded1c8feecfeb | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 2.20e-04 | 200 | 66 | 4 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | Biopsy_IPF-Epithelial-SCGB3A2+|Biopsy_IPF / Sample group, Lineage and Cell type | 2.20e-04 | 200 | 66 | 4 | 2aaf130d702d18c277d16b6800f006a53ed653fb | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.20e-04 | 200 | 66 | 4 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | Biopsy_Other_PF-Epithelial-SCGB3A2+|Biopsy_Other_PF / Sample group, Lineage and Cell type | 2.20e-04 | 200 | 66 | 4 | 631550dc34bcb605ab726645f4024d7828bb7975 | |
| Drug | Tranylcypromine hydrochloride [1986-47-6]; Down 200; 23.6uM; MCF7; HT_HG-U133A | 1.51e-05 | 195 | 62 | 6 | 2264_DN | |
| Drug | Diphenidol hydrochloride [3254-89-5]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 1.60e-05 | 197 | 62 | 6 | 7447_UP | |
| Drug | Tolmetin sodium salt dihydrate [64490-92-2]; Down 200; 12.6uM; HL60; HT_HG-U133A | 1.60e-05 | 197 | 62 | 6 | 3009_DN | |
| Drug | nordihydroguaiaretic acid; Down 200; 1uM; HL60; HT_HG-U133A | 1.69e-05 | 199 | 62 | 6 | 2683_DN | |
| Disease | alkaline phosphatase measurement | 2.57e-04 | 1015 | 62 | 9 | EFO_0004533 | |
| Disease | disease progression measurement | 2.91e-04 | 61 | 62 | 3 | EFO_0008336 | |
| Disease | asymmetric dimethylarginine measurement | 3.89e-04 | 14 | 62 | 2 | EFO_0010463 | |
| Disease | phosphatidylethanolamine measurement | 4.88e-04 | 173 | 62 | 4 | EFO_0010228 | |
| Disease | cholelithiasis | 8.54e-04 | 88 | 62 | 3 | EFO_0004799 | |
| Disease | Neurodevelopmental Disorders | 1.00e-03 | 93 | 62 | 3 | C1535926 | |
| Disease | eye measurement | 1.47e-03 | 27 | 62 | 2 | EFO_0004731 | |
| Disease | lysophosphatidylcholine 18:2 measurement | 1.59e-03 | 28 | 62 | 2 | EFO_0010361 | |
| Disease | Barrett's esophagus | 1.59e-03 | 28 | 62 | 2 | EFO_0000280 | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 1.72e-03 | 243 | 62 | 4 | EFO_0004612, EFO_0020944 | |
| Disease | airway imaging measurement | 2.91e-03 | 38 | 62 | 2 | EFO_0007627 | |
| Disease | cleft lip | 3.02e-03 | 284 | 62 | 4 | EFO_0003959 | |
| Disease | left ventricular ejection fraction measurement | 3.22e-03 | 40 | 62 | 2 | EFO_0008373 | |
| Disease | colorectal cancer, endometrial neoplasm | 3.54e-03 | 42 | 62 | 2 | EFO_0004230, MONDO_0005575 | |
| Disease | C-reactive protein measurement | 3.63e-03 | 1206 | 62 | 8 | EFO_0004458 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CHIDSVHIAMGPSAV | 351 | P59817 | |
| ETSPGHLSSHCTMPL | 506 | Q96KV6 | |
| HLSSHCTMPLVEDTP | 511 | Q96KV6 | |
| GSLCASHVLHMSPLY | 41 | Q96KT6 | |
| SSGLCFQETHLGPHM | 856 | Q6ZRH7 | |
| IRSCDDFSHMGTLPH | 61 | O75815 | |
| SPVGHSIHICSMVSF | 756 | Q8N7X0 | |
| MSESPLEGTSHCHIN | 646 | A2A2Z9 | |
| SGMISAHCNLHLPGS | 106 | Q8IV13 | |
| PHCGEAGALTHLMTA | 571 | P23109 | |
| MSHLGASTHGQTCLP | 56 | Q9H0Y0 | |
| FPHGSHSRTCDMATG | 2006 | Q9NYQ6 | |
| HTHICRGAMFPTFTS | 151 | Q8N865 | |
| VHYGHSCLIPMDTSA | 131 | Q9BZG8 | |
| NHCMLSPSSSGHLAD | 91 | Q96B23 | |
| SSHMHNTGADSPSCS | 376 | Q6VN20 | |
| KPLISNSHTDHLMGC | 701 | Q96L73 | |
| TGMCPHDIATTLQHL | 931 | Q8WYB5 | |
| EELPVICQSSSGHMH | 466 | O75147 | |
| PTAQACTMSHHPAAS | 371 | A8MXZ1 | |
| AAGLMHSDAGTSCPV | 26 | Q6ZSA7 | |
| PRHFHPSSMSVCAAV | 1246 | Q9Y6X6 | |
| PTAQACTMSHHPAAS | 371 | Q86YD7 | |
| TQSCHPDTHLAEILM | 931 | Q15751 | |
| VHQMTADAVCSPSHG | 751 | O15550 | |
| CHSEISAHSSSMGPV | 291 | Q8WYN3 | |
| PTAQACTMSHHSAAG | 371 | A8MWA6 | |
| PTAQACTMSHHPAAS | 371 | P0C7W9 | |
| THKASCDAGPMVASH | 661 | O43157 | |
| PMSRISGLHGLCHSA | 286 | Q08493 | |
| CPSASSLEIHMRSHS | 301 | Q8IX07 | |
| PTAQACTMSHHSAAS | 371 | P0DV74 | |
| ASMPQALVHCFSTHP | 76 | Q8NG92 | |
| PTAQACTMSHHSAAS | 371 | P0DV73 | |
| FMSTSPALHGLSCTA | 316 | Q9HCI7 | |
| PTAQACTMSHHSAAS | 371 | P0DV76 | |
| SHHMSPVSTKHCLVA | 146 | Q13216 | |
| SRAHDTTPMIVHCSA | 2221 | Q9UMZ3 | |
| EEEMCHHSSSSTPLA | 41 | A6NF01 | |
| SSIRTLCSMHHLVPG | 1221 | Q86UR5 | |
| PTAQACTMSHHSAAS | 371 | A6NJQ4 | |
| STTLECMATGHPHPL | 346 | A1KZ92 | |
| TSLHSMHILDGCSIS | 261 | P51685 | |
| FMHCNISSHSADLPV | 16 | P30550 | |
| LTLQCHASHDPTMDL | 526 | Q02246 | |
| CHANTSMVTHPDFAT | 61 | Q9Y2A9 | |
| PHMGRCDLTSHASAQ | 806 | Q9ULK0 | |
| PTAQACTMSHHPAAS | 371 | A6NIJ5 | |
| LDCTPTGTHDHYMLE | 51 | P50895 | |
| PTAQACTMSHHPAAS | 371 | A8MXJ8 | |
| ALPVLHGFITMHSCS | 186 | Q9NTJ5 | |
| SLHGCLAAMAPSITS | 41 | Q9BR46 | |
| AHPSGNMASFTKHIC | 121 | P19793 | |
| PTAQACTMSHHSAAG | 371 | P0C7X0 | |
| SAEHSHPALSCKMAA | 111 | O00587 | |
| VTRCGSSHKPGVHMS | 576 | Q9BVI0 | |
| SAMAPRSLSCHSVGS | 76 | Q6ZVC0 | |
| TSSCLSSHGHVMSTG | 611 | Q8NAN2 | |
| LTHMDCSTGPLSHEQ | 411 | O94941 | |
| SHSRPNTEDMSLCHA | 96 | Q8IYR2 | |
| DCALMVSAHQHPATA | 586 | O14841 | |
| PTAQACTMSHHSAAS | 371 | A8MX19 | |
| PTAQACTMSHHSAAS | 371 | A6NNJ1 | |
| PTAQACTMSHHPAAS | 371 | P0C7W8 | |
| PTAQACTMSHHPATS | 371 | D6RGX4 | |
| STYTHCEIHPSMILG | 691 | P30876 | |
| PTAQACTMSHHPAAS | 371 | P0C7V4 | |
| SPMHVVCSLSFSDSG | 451 | Q96KV7 | |
| PGHSSHVLCMAISSD | 196 | O43818 | |
| SMPVECHSSFSHSPC | 1291 | Q15413 | |
| SFSSHHLMPCDTLAR | 1306 | Q9P227 | |
| CLMTSHLESTRGHAA | 221 | O95551 | |
| HSMPSAACTISTPHH | 541 | Q5T1R4 | |
| DTHMTLPLSSVHCSV | 466 | Q96RU2 | |
| CGHFVASVPSSMLSS | 1051 | Q86YV5 | |
| PHSAAAPTCTHMFLR | 731 | Q8IYT8 | |
| AAAMACHMHIPTSGA | 566 | Q96F45 | |
| SHLLQSSMDSHCPEA | 2331 | O43149 | |
| HRSHMVIPAPSTAFC | 991 | Q9H7P9 | |
| CPSICMATPSTHSGH | 176 | Q96AQ2 | |
| PGMKSSPHDSHTCVT | 1281 | Q70EL1 | |
| PTAQACTMSHHSAAS | 371 | P0DV75 | |
| FLRSMSPHTVCSLSH | 666 | O15146 | |
| SPHTVCSLSHSDLSM | 671 | O15146 |